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ABSTRACT
Zinc for the treatment of childhood diarrhoea was introduced in a pilot area in southern Mali to prepare for 
a cluster-randomized effectiveness study and to inform policies on how to best introduce and promote zinc 
at the community level. Dispersible zinc tablets in 14-tablet blister packs were provided through commu-
nity health centres and drug kits managed by community health workers (CHWs) in two health zones in 
Bougouni district, Mali. Village meetings and individual counselling provided by CHWs and head nurses at 
health centres were the principal channels of communication. A combination of methods were employed 
to (a) detect problems in communication about the benefits of zinc and its mode of administration; (b) 
identify and resolve obstacles to implementation of zinc through existing health services; and (c) describe 
household-level constraints to the adoption of appropriate home-management practices for diarrhoea, 
including administration of both zinc and oral rehydration solution (ORS). Population-based household 
surveys with caretakers of children sick in the previous two weeks were carried out before and four months 
after the introduction of zinc supplementation. Household follow-up visits with children receiving zinc 
from the health centres and CHWs were conducted on day 3 and 14 after treatment for a subsample of 
children. A qualitative process evaluation also was conducted to investigate operational issues. Preliminary 
evidence from this study suggests that the introduction of zinc does not reduce the use of ORS and may 
reduce inappropriate antibiotic use for childhood diarrhoea. Financial access to treatments, management 
of concurrent diarrhoea and fever, and high use of unauthorized drug vendors were identified as factors 
affecting the effectiveness of the intervention in this setting. The introduction of zinc, if not appropriately 
integrated with other disease-control strategies, has the potential to decrease the appropriate presumptive 
treatment of childhood malaria in children with diarrhoea and fever in malaria-endemic areas. 
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INTRODUCTION
Diarrhoea is estimated to cause 18% of the esti-
mated 10.6 million annual deaths in children, aged 
less  than  five  years  (under-five  children),  glob-
ally (1). Meta-analyses and reviews of previous 
trials have demonstrated that 10-14 days of zinc 
treatment is associated with decreased severity and 
duration of the diarrhoea episode and lower inci-
dence  of  diarrhoea  and  pneumonia  during  two 
months following treatment, leading to decreased 
overall mortali-ty of children aged less than five Winch PJ et al. Zinc for childhood diarrhoea in Mali
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years  (under-five mortality)  (2-4).  Based  on  these 
findings, the World Health Organization (WHO) 
and the United Nations Children’s Fund (UNICEF) 
currently recommend incorporating zinc into the 
diarrhoea-management guidelines for children 
aged under five years (5). As countries revise their 
national diarrhoea-treatment guidelines, the feasi-
bility of incorporating zinc into the routine man-
agement of diarrhoea at the local level needs to be 
carefully examined (2,6,7). Only one study, in Ban-
gladesh, has assessed the effectiveness of zinc as a 
treatment for diarrhoea in a large-scale community 
effectiveness  trial  (8,9).  Studies  investigating  the 
feasibility of the introduction of zinc have recently 
concluded in Pakistan, India, and Mali, and prelimi-
nary results from formative research and pilot-test 
phases of these studies have been published (10-12). 
Finally, zinc supplementation for diarrhoea is being 
incorporated  into  the  routine  programmes  on  a 
large-scale in Bangladesh, and this roll-out is being 
carefully monitored (7,13).
One of the major concerns when introducing zinc 
into  existing  diarrhoea-management  practices  in 
the home is the potential that health providers or 
families might consider zinc a substitute for oral 
rehydration therapy (ORT), including oral rehy-
dration salts (ORS) and appropriate home-fluids. 
Zinc is a new product in a ‘fancy’ blister pack and 
may be a more attractive purchase than an ORS sa-
chet, and parents often prefer to use modern treat-
ments, which generally come in the form of pills 
or injections, to ‘cure’ diarrhoea (14). Despite these 
concerns, findings from Matlab, Bangladesh, and 
preliminary findings from India suggest that the 
promotion of zinc supplementation may increase 
the use of ORS for uncomplicated diarrhoea and 
decrease the unnecessary use of antibiotics (8,10).  
This paper describes the results of a pilot study in 
southern Mali in which various quantitative and 
qualitative methods were employed to identify 
problems relating to the introduction of this new 
intervention and suggest ways to refine the inter-
vention package prior to any large-scale imple-
mentation. The impact and feasibility of large-scale 
implementation of this intervention is currently 
being assessed in a subsequent phase of research 
that started in October 2005. Rather than a formal 
effectiveness study, the main objectives of this pilot 
study were to: (a) evaluate the community promo-
tion of zinc treatment and identify more effective 
channels of communication; (b) identify and re-
solve obstacles to implementation of zinc through 
community health centres and through a system 
of village drug kits managed by community health 
workers (CHWs); and (c) identify factors that may 
facilitate or impede the adoption of appropriate 
home management of diarrhoea, including supple-
mentation with zinc.
MATERIALS AND METHODS
Study site 
The study was carried out in two health zones in 
Bougouni district, located in southern Mali. Study 
participants mostly belong to the Bambara ethnic 
group, speak Bambara in the home, and reside in 
large compounds whose members belong to the 
same extended family. Each of these health zones 
has a population of 12,000-17,000 and is served 
by one community health centre (equivalent to 
health posts or dispensaries in other African coun-
tries) and a network of village drug kits managed 
by CHWs. Each health zone has approximately 8-
10 village drug kits located in larger villages (>500 
inhabitants) that are located five km or further 
from the health centre. The village drug kits con-
tain products for common illnesses in the com-
munity, including antimalarials, paracetamol, and 
ORS. The CHW maintains these medications in a 
wooden cabinet in his or her household within the 
community. The CHWs attend supervisory meet-
ings and restock their medications at the commu-
nity health centre.
Methods of intervention
Zinc was provided through the community health 
centres and the village drug kits managed by the 
CHWs.  The  health  centre  staff  and  CHWs  were 
trained on (a) diarrhoea case management with 
zinc and ORS, (b) counselling of parents on child-
feeding and prevention and treatment of diar-
rhoea, and (c) recording routine data in notebooks. 
Zinc was distributed in a 14-count blister package 
of dispersible tablets. The recommended regimen 
consisted of one 20-mg tablet per day for children 
aged six months or older and half a tablet, or 10 mg 
per day, for children aged less than six months (5).   
Zinc was introduced through the existing distribu-
tion system for medications, based on the Bamako 
Initiative, which involves recovery of costs at each 
level (15-17). At the community health centres, vil-
lagers are charged a consultation fee and also pay 
separately for any prescriptions obtained—profits 
are, however, used for paying salaries of staff, main-
taining the centre and equipment, and restocking 
supplies and medications. The CHWs volunteer 
their services, but charge for medications to replen-Winch PJ et al. Zinc for childhood diarrhoea in Mali
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ish their stocks in the drug kits and cover additional 
operational costs. In principle, any additional 
revenues from the drug kits are split between the 
CHW and village oversight committees as an in-
centive for their continuing work. However, lack of 
adequate incentives for the CHWs is an ongoing 
challenge in this programme. The cost of zinc to 
patients at the health centres and CHWs was 100 
CFA Francs (~0.19 US$) for the full package of 14 
tablets and 50 CFA Francs (~0.09 US$) for a half blis-
ter package of seven tablets (for children aged less 
than 6 months). Zinc supplies were stored at the 
District Drug Warehouse at the referral hospital 
in Bougouni until purchased by the community 
health centres, which, in turn, supplied the CHWs. 
At the start of the intervention, the community 
health centres and CHWs were given a zinc supply 
estimated to last for two months. This supply chain 
for zinc was largely effective during the brief period 
of the pilot introduction, and no stock-outs were 
reported. However, the system is especially vulner-
able to stock-outs at the CHW level, and stock-outs 
of ORS packets did occur in the community.
The promotion of zinc supplementation for the pi-
lot intervention was done primarily through village 
meetings and individual counselling provided by 
the CHWs and head nurses at the health centres. 
The CHWs also promoted zinc treatment at com-
munity events, such as baptisms, marriages, and re-
ligious holidays. Key messages and visual aids were 
developed based on findings of a formative phase of 
research (11); they were used primarily by the proj-
ect field supervisor during community meetings.
Evaluation methods
Various methods were used for examining opera-
tional difficulties encountered in the pilot imple-
mentation of this intervention; these methods are 
briefly described here.
Population-based household surveys: Population-
based household surveys with caretakers of chil-
dren sick in the previous two weeks were carried 
out before (March-April 2004) and four months af-
ter the introduction of zinc supplementation (Sep-
tember 2004). Lists of all the housing compounds 
in each village located in the two pilot health zones 
and their approximate size were compiled. Hous-
ing compounds were chosen proportional to their 
size using a systematic sampling scheme. If there 
were two or more sick children residing in the com-
pound, the interviewer drew the name of one of 
the children through lottery. If there was no sick 
child or the caretaker did not consent, the com-
pound was replaced with the housing compound 
to the right. The surveys gathered data on: (a) treat-
ment practices for diarrhoea, including the use of 
ORS, antibiotics, and zinc; (b) care-seeking from 
both health facilities and alternate providers; and 
(c) knowledge and use of zinc supplementation. In-
terviewers were initially trained for five days, with a 
three-day refresher training before the final survey. 
The baseline and final questionnaires, translated 
from French into Bambara collaboratively by the 
study team and interviewers, were pretested in an 
adjoining health zone and modified accordingly. 
In total, 352 surveys at baseline and 351 final sur-
veys were carried out.
Household follow-up visits: Household follow-up 
visits with children receiving zinc from the health 
centres and CHWs were conducted on day 3 and 
14 after treatment for a subsample of children. 
These surveys collected information describing the 
administration of zinc, purchasing patterns, com-
pliance, attitudes, and caregiver satisfaction and 
monitored for adverse outcomes or side-effects of 
zinc, such as vomiting, convulsions, or death. This 
component of the study is described in more detail 
elsewhere (12).
Process  evaluation  through  collection  of  qualitative 
data: A three-person team not involved in the in-
tervention implementation conducted the pro-
cess  evaluation  through  collection  of  qualitative 
data. Interviews with the CHWs managing village 
drug kits were carried out to obtain information 
about the overall implementation of the interven-
tion, including: training, supervision, community 
promotion, the use of zinc, management of diar-
rhoea, and the operational aspects of the CHW sys-
tem (n=28). Semi-structured interviews were con-
ducted with mothers, fathers, and other caretakers 
of young children regarding care-seeking and home 
management for childhood diarrhoea, knowledge 
and perceptions of the zinc intervention activi-
ties, knowledge and perceptions of the village drug 
kit system, and financial access to zinc and other 
medications. Interviewees were selected to include 
both families using zinc (n=28) and those not us-
ing zinc (and/or ORS) (n=9). CHW training sessions 
(n=3) and community meetings (n=13) promoting 
improved management of diarrhoea were directly 
observed and carefully documented. Information 
about children treated for diarrhoea was also col-
lected and compiled from registers in the commu-
nity health centres and CHW records (notebooks) 
through regular monitoring activities. 
Because of the variety of methods employed, when 
quantitative data are cited in the text or tables, the Winch PJ et al. Zinc for childhood diarrhoea in Mali
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data-collection method and sample size are indicat-
ed. This pilot introduction was not powered to detect 
differences between baseline and final surveys; how-
ever, we present these data to demonstrate observed 
trends associated with the introduction of zinc.  
Ethical approval
The study received ethical approval from the Com-
mittee for Human Research of Johns Hopkins Uni-
versity  Bloomberg  School  of  Public  Health  and 
from the Internal Review Board of the Faculty of 
Medicine, Pharmacy, and Dentistry, University of 
Bamako. Consent in each participating village was 
obtained from village leaders, and parents were 
asked for consent prior to interviews. 
RESULTS
Awareness and use of zinc supplementation
Reaction to zinc supplements as a diarrhoea treat-
ment was largely positive, and community mem-
bers appreciated the packaging, the taste of the 
tablets, and the outcomes seen in their children 
post-administration. Community perceptions of zinc 
treatment were presented in more detail else-
where (11,12). The promotion of zinc and im-
proved management of diarrhoea was carried out 
primarily through community meetings conducted 
by the CHWs in their villages. In the final house-
hold survey conducted four months after the in-
troduction of zinc, only 99 (28%) of 351 caretak-
ers interviewed in the two health zones had any 
knowledge of zinc; however, 81 (59% of 137care-
takers of sick children who lived in villages with a 
CHW had knowledge of zinc.
The reported use of zinc for children sick with diar-
rhoea during the previous two weeks was relatively 
low (17%), four months after the introduction of 
zinc (Table 1). Of children with diarrhoea residing 
in villages with a CHW, use of zinc was much high-
er at 66% (29/44); however, only nine (5%) of 176 
children with diarrhoea in villages without CHWs 
were reportedly given zinc supplementation in the 
previous two weeks (p<0.001).
Table 1. Reported home management and sources of care visited among young children with diar-
rhoea in the previous 2 weeks before and 4 months after the introduction of zinc treatment
Reported practices
Baseline:
before introduction of 
zinc (n=228)
Final:
4 months after intro-
duction of zinc
(n=220)
No. % No. %
Treatments administered*
   Zinc Not available   38 17.3
   Oral rehydration salts   25 11.0   40 18.3
   Antibiotics 130 57.0 104 47.3
   Metronidizole   17  7.5    8   3.6
   Antidiarrhoeal    6  2.6    2   1.0
Home-management practices*
   Sugar salt solution Question not asked    7 3
   Continued feeding or continued 
     breastfeeding 123 54.0 125 56.8
   Increased liquids or increased
     breastfeeding   39 17.1   73 33.2
Source of care visited*
   Community health centre or 
     referral health centre   69 30.3   63 28.6
   Community health worker   22   9.7   42 19.1
   Unlicensed, informal sector vendor** 100 43.9   78 35.5
*Not mutually exclusive; **Includes market stalls, small shops, and ambulatory vendors
Data-collection method: Population-based survey in households with caretakers of sick children 
Population (n): 228 (baseline survey) and 220 (final survey) children whose caretakers reported 
having a diarrhoeal illness in the previous 2 weeks 
Timing of data collection: Before introduction of zinc treatment (April 2004) and 4 months after 
introduction of zinc treatment (September 2004)Winch PJ et al. Zinc for childhood diarrhoea in Mali
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The effect of the introduction of zinc supplementa-
tion on care-seeking patterns by families for episodes 
of childhood diarrhoea was estimated, although 
definitive conclusions cannot be drawn due to the 
design of this pilot study. As Table 1 demonstrates, 
four months after the introduction of zinc, there 
was little change in levels of care-seeking from the 
community health centres or from unlicensed, in-
formal sector vendors who commonly sell antibio-
tic capsules as a treatment for diarrhoea. However, 
there was a two-fold increase in reported care-seek-
ing from the CHWs associated with the introduc-
tion of zinc supplementation. Even at the conclu-
sion of the study, the CHWs remained a much 
less common source of care for diarrhoea than the 
health centres and informal sector providers. This 
is due partly to the fact that their role in the treat-
ment of malaria has received greater emphasis in 
recent years than their role in the treatment of di-
arrhoea, and also because only the larger villages 
have a CHW. 
Incorporation of zinc into existing diarrhoea-
management strategies
The facility-based health workers and CHWs easi-
ly incorporated zinc supplementation into their 
management of childhood diarrhoea. The prescrip-
tion of the correct dosage of zinc was, overall, sat-
isfactory, with a few difficulties, and is described 
elsewhere (12). The health centre staff and CHWs 
were instructed to recommend the purchase of ORS 
sachets in addition to zinc. In accordance with the 
Malian Ministry of Health policy of the time, if par-
ents did not or could not purchase the ORS sachets, 
they were encouraged to prepare sugar salt solution 
(SSS) in their homes. 
The use of ORS and other rehydration therapies 
was closely monitored in this pilot study. In house-
hold follow-up of children treated with zinc at the 
health centres and by the CHWs (n=123), 64% were 
prescribed  and  administered  ORS  in  addition  to 
zinc (Table 2). Of those caretakers who purchased 
zinc but did not purchase ORS sachets, 62% report-
ed that they were counselled about how to prepare 
SSS in their homes. Although we do not have com-
parable data on providers’ prescribing practices of 
ORS before the introduction of zinc, there is little 
reason to believe that ORS or SSS was recommended 
at any lesser extent because of zinc. In fact, qualita-
tive data suggest that the providers and CHWs pres- 
cribed and emphasized ORS, SSS, and home-fluids 
more than before because of the training associated 
with the introduction of zinc and renewed empha-
sis on management of diarrhoea. In some cases, 
mothers even reported that the CHWs prepared 
SSS for them when they indicated that they could 
not afford to purchase ORS, although the use of SSS 
reported in the final survey remained low (Table 1). 
Data from household surveys also suggest that this 
limited introduction of zinc did not reduce either 
use of ORS or administration of increased fluids in 
the home for children with diarrhoea (Table 1). 
Before the introduction of zinc, only 11.0% of the 
caretakers reported the use of ORS sachets for the 
diarrhoea episode of their children in the previous 
two weeks, an estimate comparable with the most 
recent DHS survey (18). The proportion of children 
receiving ORS for diarrhoea four months after the 
introduction of zinc was 18.3%; a 63% relative in-
crease over the baseline estimates.  
Non-recommended treatments for diarrhoea 
and competing sources of modern treatments
The use of modern medications for childhood diar-
rhoea is extremely high in southern Mali, and many 
treatments are purchased through the private sector, 
primarily comprising village markets stalls and am-
Table 2. Treatments children received (in addition to zinc) by symptom complex
Reported symptom 
complex
No.
ORS Antibiotic Antimalarial Paracetamol
No. % No. % No. % No. %
Diarrhoea only 31 15 48 5 16 5 16 3 10
Diarrhoea + fever 36 22 61 1 3 3 8 4 11
Diarrhoea + ARI* 23 18 78 7 30 7 30 3 13
Diarrhoea + ARI* + fever 33 24 73 6 26 6 18 6 18
Total 123 79 64 21 17 21 17 16 13
*Reported symptoms of cough, raised respiratory rate, respiratory difficulties, chest pain, and/or 
chest in-drawing; ARI=Acute respiratory infection; ORS=Oral rehydration solution
Data-collection method: Follow-up survey in household with caretakers of children receiving zinc 
Population (n): 123 caretakers whose children received zinc from CHWs or health facilities
Timing of data collection: 4-12 weeks after the official introduction of zinc treatmentWinch PJ et al. Zinc for childhood diarrhoea in Mali
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bulatory vendors (19). Almost 44% of children with 
diarrhoea received treatment from these unauthor-
ized, private providers in the baseline survey (Table 
1). Only 3% of children with diarrhoea received an 
antidiarrhoeal. However, treatment with antibiot-
ics was very common, with 57% of children with 
diarrhoea  reportedly  receiving  some  antibiotics  in 
the baseline survey. While 23% of antibiotics were 
purchased from the health centre, almost half (49%) 
was purchased in the market, with another 13% pur-
chased from unauthorized village vendors.  
Parents often purchase a few pills at a time at these 
locations, and during the course of our research, 
parents frequently expressed their preference of 
having the flexibility of only purchasing as much 
or as little medication as they could afford. A CHW, 
who is recognized by the Ministry of Health, and 
can provide certain treatments, such as antimalari-
als, paracetamol, ORS sachets, and also zinc in our 
study zones, explained the issue as follows: 
“The difficulty that we have is the fact that certain 
people bring only 10 francs or 15 francs to buy 
medications. If you tell them that you cannot sell 
them just 10 or 15 francs worth of medication, they 
get angry and say that, although there is a drug kit, 
they still cannot get medications … or, as people 
are used to buying yalayalafura [general term for 
drugs sold in the market or by ambulatory vendors] 
where there are products for 10-15 francs, they may 
think that it is the same thing [as medicines from 
the CHW].”
Although some children likely required antibiotic 
therapy for co-morbidities or dysentery, evidence 
showed that parents preferentially sought out an-
tibiotics in cases of uncomplicated diarrhoea, es-
pecially from non-authorized providers. Among 
all sick children (n=352) surveyed at baseline, any 
reported symptom of diarrhoea was strongly and 
significantly associated with obtaining antibiotics 
from an unauthorized source (unadjusted odds ra-
tio=9.4; 95% confidence interval 4.57-19.58) either 
exclusively or in addition to an antibiotic from a 
public-health facility. Four months after the intro-
duction of zinc, it was estimated that 47% of chil-
dren with diarrhoea were treated with antibiotics, 
an 18% relative decrease from the baseline esti-
mates of antibiotic use.  
Zinc supplementation for diarrhoea and man-
agement of children with multiple symptoms 
In Mali, children frequently have multiple symp-
toms concurrently and rarely present with one ill-
ness. During the baseline survey, of 352 sick chil-
dren,  approximately  22%  reported  symptoms  of 
acute respiratory infection (ARI), fever, and diar-
rhoea, 35% reported fever and diarrhoea, and 17% 
reported fever and ARI. A similar profile of multiple 
symptoms was also seen in children who presented 
for care at community health facilities or CHWs. 
Table 3 shows that  children treated with zinc re-
ceived from the CHWs were more likely to report 
diarrhoea as their only symptom than those chil-
dren treated at the health facilities. However, very 
few children who were treated with zinc presented 
with diarrhoea alone in either location, and in both 
cases, over 70% of children with diarrhoea also had 
fever, ARI symptoms, or both. 
The community health centre staff members in-
cluded nurses who have received training on Inte-
grated Management of Childhood Illness (IMCI), 
and the CHWs were trained for community-based 
Table 3. Symptom patterns of children receiving zinc treatment for diarrhoea at village drug kits 
or health centres during the zinc pilot study
Reported symptom complex
Total
(n=123)
No.             %
Presenting to village 
drug kit (n=102)
No.              %
Presenting to com-
munity health 
centre (n=21)
No. %
Diarrhoea only 31 25 28 27 3 14
Diarrhoea + fever 36 29 30 29 6 29
Diarrhoea + ARI* 23 19 17 17 6 29
Diarrheoa + fever + ARI* 33 27 27 27 6 29
*Reported symptoms of cough, raised respiratory rate, respiratory difficulties, chest pain, and/or 
chest in-drawing
Data-collection method: Follow-up survey in household with caretakers of children receiving zinc
Population (n): 123 caretakers whose children received zinc from CHWs or health facilities
Timing of data collection: 4-12 weeks after the official introduction of zinc treatmentWinch PJ et al. Zinc for childhood diarrhoea in Mali
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distribution of medicines for the treatment of malaria. 
The training modules developed and implemented 
at the start of the pilot intervention focused almost 
exclusively on the management of diarrhoea and did 
not address the management of other childhood ill-
nesses, such as malaria. Despite previous training of 
health workers on the management of fever, the moni- 
toring of health workers’ registers and follow-up 
of children treated with zinc revealed that many 
parents of children presenting with both diarrhoea 
and fever purchased only zinc tablets and ORS sa-
chets, but did not purchase chloroquine (the rec-
ommended treatment for all cases of fever at the 
time of the study). Table 2 presents the treatments 
given to sick children, in addition to zinc received 
from the health facilities and CHWs, as reported 
in household follow-up interviews. These figures 
also include those treatments obtained from other 
sources that were given before or after receiving zinc 
supplementation, as many children receive treat-
ments from various sources of care. For example, 
in some cases, children with fever and diarrhoea 
received chloroquine from another source, such as 
a private vendor, before presenting to a CHW for 
zinc. Eighteen percent of children with symptoms 
of diarrhoea, fever, and ARI received an antima-
larial; children with symptoms of diarrhoea and fe-
ver were even less likely to receive an antimalarial. 
Treatment of fever with an antipyretic medication 
(paracetamol) was equally poor.   
Due to the difficulties encountered in clinical man-
agement of children with fever and diarrhoea, pat-
terns of treatment for children with symptoms of 
diarrhoea and fever were also further examined 
through interviews with parents. Although zinc 
was promoted only for diarrhoea in this study, 20% 
of 99 caretakers who had heard of zinc interviewed 
in the final survey stated that zinc can treat malaria, 
and 9% stated that zinc can treat fever (Fig. ). It was 
also found that community perceptions concerning 
the effectiveness of modern versus traditional treat-
ments for certain illnesses might play a role in this 
phenomenon. Previously, children often received 
only chloroquine for diarrhoea with fever. After the 
introduction of zinc, when questioned in in-depth 
interviews, many parents prioritized the purchase 
of zinc to treat children with diarrhoea and fever. 
One of the primary reasons was the perception that 
there are effective traditional treatments for malar-
ia, but not for diarrhoea and that diarrhoea takes 
away child’s strength and, thus, is a more serious 
illness. As one parent explained:
“Malaria (sumaya) is easier to treat than diarrhoea. I 
would begin by treating diarrhoea. There are many 
treatments for malaria and traditional medicines, 
which are effective, but for diarrhoea … before, we 
used kunbléni (antibiotic capsules, often tetracy-
cline), but it is not effective, and we mostly use it 
for severe diarrhoea (konorojoli). Therefore, even if I 
could not buy the malaria medications, I could use 
the traditional medicines for that.”
Financial access to zinc and other medications
In qualitative interviews, most caretakers noted that 
they found zinc affordable, although some caretak-
Fig. Perceptions of symptoms zinc can treat among 99 caretakers who reported knowledge of zinc
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ers who did not ultimately seek care for their children’s 
diarrhoea stated that the primary reason was due 
to a lack of funds. In the final household survey, 
caretakers who reported knowing the price of zinc 
were asked their opinion concerning its cost. Of 77 
caretakers, 72% stated that zinc was inexpensive or 
affordable, while 6% said that it was expensive or 
very expensive (22% had no opinion). While the 
cost of zinc alone may not be prohibitive, when a 
child presents with multiple illnesses, the total cost 
of the recommended multiple treatments is not af-
fordable for many families. Before zinc, standard 
treatment for simple diarrhoea was often tradition-
al remedies or home-fluids supplemented by a few 
antibiotic pills, frequently tetracycline (commonly 
called kunbléni in Bambara), purchased in the mar-
ket for a minimal cost (11). Consequently, indivi-
dual families spent far more on treating childhood 
diarrhoea than previously if they administered all 
the  treatments  recommended  by  the  project  for 
management of diarrhoea. When diarrhoea was 
accompanied by fever, the cost of appropriate treat-
ments was even more pronounced. 
DISCUSSION
This study is the first to document the operational 
issues and examine the trends associated with the 
introduction of zinc supplementation for diarrhoea 
in a sub-Saharan setting; previously-published re-
search from Asia concerning community introduc-
tion of zinc may be only partially applicable in Afri-
can settings. Through the evaluation process of the 
mixed methods employed in this pilot study, we 
could identify important constraints to the intro-
duction of zinc in this setting, such as the manage-
ment of concurrent diarrhoea and fever, high use 
of unauthorized drug vendors, and limited finan-
cial access to treatments. We also observed positive 
trends in key indicators associated with this small-
scale introduction of zinc; these include: (a) in-
creased care-seeking to the CHWs for childhood di-
arrhoea, (b) increased use of ORS, and (c) decreased 
antibiotic use for childhood diarrhoea. The impact 
of the larger-scale introduction of zinc on these im-
portant indicators are currently being examined in 
Mali in a community-randomized trial, specifically 
designed to measure these outcomes. 
Awareness and use of zinc supplementation
The use of zinc supplementation for childhood 
diarrhoea was much lower than expected four 
months after the introduction of zinc into the 
health system. In villages where the CHWs were 
providing zinc supplementation to young children 
with diarrhoea, the use of zinc was much higher. 
Knowledge of zinc supplementation was also sig-
nificantly better in villages with the CHWs who 
were engaged in community promotion. We also 
observed a significant increase in care-seeking to 
the CHWs for childhood diarrhoea when zinc was 
introduced. These findings suggest that the CHWs 
are an effective means for promoting and providing 
zinc supplementation in communities in this set-
ting, increasing access to and awareness of the new 
intervention beyond the health centres. However, 
the relatively low proportion of villages covered by 
the CHWs in this area (18 villages with Save the 
Children-supported CHWs among 48 villages and 
hamlets) limits the potential impact of distribution 
and promotion of zinc through the CHW system 
on a population level. 
To improve the awareness and use of zinc supple-
mentation at a population level, village drug kits 
managed  by  trained  CHWs  could  be  established 
in all villages further than five km from a commu-
nity health centre. This would require significantly 
more funding and programmatic effort, as villages 
tend to be dispersed, so supervision and support 
of CHWs would be more expensive. Distributing 
zinc through private vendors of modern medicines 
is  another  alternative,  especially  in  this  setting 
where vendors are a common source of treatment 
for childhood diarrhoea. Despite the elevated use 
of these providers, zinc was not provided via this 
system in this pilot for the following reasons: (a) 
very few private outlets or vendors are sanctioned 
by the Government; (b) many vendors are without 
a fixed place of work; (c) some vendors are children 
as young as 8 or 9 years of age; (d) it is difficult to 
monitor  side-effects  and  outcomes  of  zinc  treat-
ment obtained from these sources of care; and (e) 
it is difficult to assure the quality of the product, 
as the sources of medications in the informal sec-
tor have not yet been determined. However, in the 
future, private providers and/or vendors might be 
involved in the distribution of zinc. Because zinc 
is a micronutrient with no chance of evolving re-
sistance and has very few documented side-effects, 
obtaining  government  approval  for  such  an  ap-
proach may be less complicated than efforts to gain 
permission for distributing antimicrobials, such as 
antimalarials, in the private sector.  
Additional channels of communication should 
also be used for reaching desired levels of cover-
age. Other evaluations in Africa have found social 
marketing using mass media to be an effective Winch PJ et al. Zinc for childhood diarrhoea in Mali
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means of health promotion (20), although where 
communities are dispersed and have limited access 
to modern media, coverage achieved through na-
tional media alone will be insufficient (20-22). In 
this area, community-based promotion of zinc as 
a new treatment could include broadcasts on local 
radio stations and promotion by health centre staff 
at vaccination days at the health centre, during an-
tenatal visits, or when facility-based nurses make 
monthly visits to villages for vaccination, distribu-
tion of vitamin A, and other public-health activi-
ties. Suggestions given by the CHWs and project 
staff for other strategies appropriate to the Malian 
context include: (a) plays created by theatre groups, 
(b) drumming and/or dancing with the zinc mes-
sages, (c) messages about zinc broadcast during 
village special events, (d) information taught in 
schools so students will pass along information 
to their parents, and (e) skits developed and per-
formed by school students in the villages. 
Incorporation of zinc into current diarrhoea-
management practices
Although this pilot phase of the study was not 
designed to measure changes in the use of ORS, 
the results suggest that introducing zinc into the 
management of diarrhoea may improve the use of 
ORS, a result similar to that found in Bangladesh 
and India (8,10). We also observed that the intro-
duction of zinc supplementation did not reduce 
administration of increased fluids in the home; in 
fact, there was an increase in recommended home 
care associated with the introduction of zinc sup-
plementation.
The Ministry of Health, Mali, now no longer re-
commends the use of SSS. In accordance with the 
recommendations of WHO and UNICEF (5), the 
Ministry of Health has revised their policy to pro-
mote increased appropriate home-fluids (and con-
tinued feeding) for children with diarrhoea. Because 
the administration of appropriate home-fluids is 
simpler to explain and carry out than the prepara-
tion of SSS, it is hoped that this new approach will 
improve both promotion of ORT by health work-
ers during consultations and subsequent adminis-
tration of ORT by parents in the home. The new 
low-osmolarity ORS formulation, which has been 
shown to reduce stool output, vomiting, and un-
scheduled intravenous infusions (23-25), is not yet 
available in Mali. When this new ORS formulation 
becomes available, health workers should promote 
this product along with zinc to families as an im-
proved, more efficacious diarrhoea-management 
package. 
Non-recommended treatments for diarrhoea 
and competing sources of modern treatments
In Mali, many parents perceive that childhood di-
arrhoea is better treated with antibiotic capsules, 
and purchase of antibiotics from the informal sec-
tor for childhood diarrhoea is extremely common. 
In this setting, zinc has a great potential to replace 
antibiotics as a ‘medicine’ for diarrhoea, thereby 
decreasing overall antibiotic use among children. 
Our evidence points to a slight decrease in antibiot-
ic use and a small decrease in care-seeking to unau-
thorized medicine vendors associated with the in-
troduction of zinc supplementation. These results 
are comparable with a recent study in Bangladesh 
which found that 13% of children with diarrhoea 
living in zinc clusters were being treated with an-
tibiotics for their diarrhoea episodes compared to 
34% of children with diarrhoea living in control 
clusters (p<0.01) (8). To reinforce these trends, pro-
motional messages accompanying introduction of 
zinc should discourage antibiotic use for non-dy-
senteric cases of diarrhoea. Because parents are ac-
customed to purchasing and administering a few 
pills or capsules from market vendors for an epi-
sode of diarrhoea, the longer-term preventative as-
pects of zinc supplementation (4,9), and, thus, the 
potential reduction in future medicine purchases, 
should also be emphasized in these promotional 
activities. 
Zinc supplementation for diarrhoea and man-
agement of children with multiple symptoms 
Insufficient attention devoted to the management 
of multiple symptoms during the training of CHWs 
and health centre staff was the largest operational 
issue encountered by our study team. Within two 
weeks of noting the deficiency in management of 
children who present with fever and diarrhoea, 
day-long meetings were held, in cooperation with 
the local health authorities, to address this short-
coming of the intervention. It was decided to pro-
vide follow-up ‘refresher’ training to the CHWs. 
Discussions during this training and subsequent 
interviews with the CHWs revealed that many of 
them had been working under the misconception 
that the combination of treatments was not nece-
ssary. During the refresher training, the CHWs 
stated, “we did not know that it is necessary to 
also treat malaria; we believed that treatment of 
diarrhoea was sufficient,” and asked whether, 
“the child could handle two treatments at once,” 
reflecting local perceptions that some medicines 
and medicine combinations are too powerful for 
children. A review of drug kit registers (notebooks) Winch PJ et al. Zinc for childhood diarrhoea in Mali
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and a second series of interviews after the refresher 
trainings confirmed that the CHWs were appropri-
ately managing children presenting with diarrhoea 
and fever.
Health programmes must take two basic steps to 
ensure adequate management of children with 
multiple conditions. First, programmes must en-
sure that health workers treat all the children’s 
conditions adequately. Zinc must be incorporated 
into an integrated package of disease management 
and cannot be introduced in isolation. Training 
must also cover management of common combi-
nations of presenting symptoms, such as diarrhoea 
and fever, or diarrhoea and ARI. Job aids and regis-
ters/notebooks for recording symptoms and treat-
ments should be designed with the presentation of 
multiple symptoms taken into consideration. Ade-
quate management of all symptoms will likely be 
facilitated in areas implementing Integrated Man-
agement of Childhood Illness (IMCI), which has 
been shown to improve the quality of care for sick 
children in facilities (26). 
Second, programmes must ensure that parents pur-
chase and administer all the required medications 
for children presenting with multiple symptoms. 
This is a particular concern as Mali makes the tran-
sition to artemisinin combination therapy (ACT) 
as the first-line treatment for malaria. If zinc and 
ACTs are introduced concurrently, this may com-
pound the challenge of adequately explaining how 
to manage sick children to parents and first-level 
and voluntary health workers, as both are new 
treatments for common childhood illnesses. A child 
presenting with diarrhoea and fever may be pres-
cribed an antimalarial, an antipyretic, zinc, and 
ORS. Health workers will require more detailed 
counselling guidelines for explaining the impor-
tance of purchasing multiple treatments and how 
to administer various medications.  
Financial access to zinc and other treatments
The introduction and promotion of zinc supple-
mentation, along with improved management of 
diarrhoea, results in families spending more on 
treatment of diarrhoea than they are accustomed. 
This will force poor families to make difficult choic-
es—which one of the life-saving treatments recom-
mended for their sick child will they purchase? This 
study  has  demonstrated  that  when  a  new  treat-
ment, such as zinc supplementation for diarrhoea, 
is introduced, although its cost is minimal, parents 
may try to judge which treatment is the most im-
portant and purchase only that one treatment. 
When multiple treatments, such as antimalarials, 
zinc, and ORS, are prescribed, the poorest families 
may gravitate to the lowest treatment cost. Given 
the high cost of new combination treatments for 
malaria, there is a real possibility that many fami-
lies will purchase zinc instead of antimalarials when 
their children present with fever and malaria. If 
new combination treatments for malaria are highly 
subsidized or free to parents, there is the possibility 
that children presenting with fever and diarrhoea 
may only receive an antimalarial.
It is increasingly recognized that there is a moral im-
perative for governments and donor organizations 
to make more expensive life-saving treatments, 
such as antiretroviral therapy for AIDS and arte-
misinin combination therapy for malaria, available 
free of charge or at a minimal price to those who 
are in desperate need, but could never afford to pay 
for them. A similar consensus in support of subsi-
dizing treatments for diarrhoea has yet to be mate-
rialized. One reason is that low-osmolarity ORS and 
zinc in a sense are affordable. Families could bor-
row from a neighbour or sell some of their belong-
ings to purchase ORS and zinc recommended for 
their sick children, and intensive marketing of zinc 
might convince them to do this on a regular basis. 
But this is a dangerous zero-sum game. Improved 
management of diarrhoea may mean inadequate 
management of other illnesses or decreased spend-
ing on food. The experience from this study in Mali 
suggests that families who are carefully husband-
ing their scarce resources often will fail to purchase 
and administer all the recommended treatments 
for their sick children, when multiple treatments 
are recommended. We believe that there is a com-
pelling case for governments and donor organiza-
tions making the commitment to ensure that zinc 
is available free of charge or at a nominal cost, if we 
hope to see its life-saving potential realized.
For children with multiple symptoms, policy-mak-
ers need to ensure that there is no financial pen-
alty for purchasing multiple essential treatments 
for sick children. As new drugs are introduced for 
diarrhoea, malaria, and other illnesses, policy-mak-
ers need to examine the costs that will be incurred 
when different combinations of symptoms are 
treated and develop policies for subsidization that 
will not only make expensive medications, such as 
artemisinin  combination  therapy  affordable,  but 
also promote rational treatment behaviour for chil-
dren with multiple symptoms. 
In Mali and in similar health systems based on cost-
recovery, credit is often extended to families in the Winch PJ et al. Zinc for childhood diarrhoea in Mali
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community who cannot afford to pay for medica-
tions recommended by the CHWs, especially during 
the rainy season. When credit is extended but never 
repaid, the CHWs are still responsible for replenish-
ing their supplies and at times have to use personal 
funds to purchase new stocks and/or to obtain trans-
portation to the health centre to purchase these 
stocks. In a region where personal funds are often 
extremely limited, this can lead to stock outs. Prob-
lems  relating  to  financial  access  not  only  impact 
individual families, but can also negatively impact 
the distribution systems. Therefore, decisions about 
total or partial subsidization of zinc and ORS need 
to consider not only how to ensure financial access 
to these treatments for the poorest families, but also 
how to ensure the sustainability of community-
based distribution systems that rely on voluntary or 
semi-voluntary workers, such as CHWs.
Our findings demonstrate that factors, such as man-
agement of concurrent diarrhoea and fever, high 
use of unauthorized drug vendors, and financial 
access to treatments are crucial factors affecting the 
effectiveness of zinc treatment when introduced 
into routine programmes. Preliminary evidence 
from this pilot study suggests that the introduction 
of zinc does not reduce the use of ORS; in fact, it 
has the potential to reinvigorate existing diarrhoea-
management strategies and to reduce inappropriate 
antibiotic use for simple diarrhoea. A community-
based cluster randomized trial is currently under-
way to examine the impact of the introduction of 
zinc on diarrhoea-management practices, such as 
use of ORS, seeking care at the community health 
centres and CHWs for childhood diarrhoea and an-
tibiotic use for simple diarrhoea.  
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